Boston Scientific accounts are for healthcare professionals only.
Discover how Illumina 3D™ streamlines DBS programming and makes this proven therapy more accessible in routine clinical care.1
DBS tools & support for your practice
Hear from one general neurologist on expanding patient access to DBS
Gain insights into the challenges patients face navigating the path to DBS and discover ways you can help streamline that pathway.
With Boston Scientific’s latest advancements in DBS programming, this safe and effective therapy is now practical within everyday clinical workflows. Illumina™ 3D simplifies DBS programming to support efficient care and improved patient outcomes in under 20 minutes.1
250,000+ patients have received DBS therapy2
96% of patients would choose DBS again3
Hear from your peers
How DBS Changed My Practice
A General Neurologist's perspective
Boston Scientific EDUcare wordmark
Online General Neurology education
The EDUCARE online platform makes healthcare education and training more relevant, more comprehensive, more personal, and more accessible. Register to access a library focused on integrating DBS into your general neurology practice.
Resources to help you and your patients move forward with confidence
Support and education designed to meet the needs of both your practice and your patients.
- Referral forms and tools
- Patient education materials
- Provider education resources
Tools and resources for you and your patients to support DBS care in your practice
Boston Scientific sponsored the first double-blinded, sham-controlled study on DBS for PD patients which demonstrated:4,5
6 more hours of "ON-time" daily
51% improvement in UPDRS III at 1 year
Sustained motor improvement for at least 5 years
A prospective multicenter international registry for ET showed:6
A mean increase of 9 hours/day without tremor at one year
12 months of clinically significant improvement in Quality of Life (QoL)
1. Lange F, et al. (2021). Reduced Programming Time and Strong Symptom Control Even in Chronic Course Through Imaging-Based DBS Programming. Front. Neurol. 12:785529.doi: 10.3389/fneur.2021.785529 n=10
2. Johnson KA, et al. Proceedings of the 11th Annual Deep Brain Stimulation Think Tank: pushing the forefront of neuromodulation with functional network mapping, biomarkers for adaptive DBS, bioethical dilemmas, AI-guided neuromodulation, and translational advancements. Frontiers in Human Neuroscience. 2024 Feb 21;18:1320806. doi: 10.3389/fnhum.2024.1320806. (250,000 patients implanted)
3. Knoop CD, Kadish R, Hager K, Park MC, Loprinzi PD, LaFaver K. Bridging the gap in patient education for DBS surgery for Parkinson’s disease. J Parkinson’s Dis. 2017;2017:9360354. doi:10.1155/2017/9360354.
4. Vitek JL, et al. Subthalamic nucleus deep brain stimulation with a multiple independent constant current controlled device in Parkinson’s disease (INTREPID): A multicentre, double-blind, randomised, sham-controlled study. The Lancet Neurology. 2020;19(6):491-501. https://doi.org/10.1016/S1474-4422(20)30108-3
5. Starr, Philip A., et al. “Five-Year Outcomes from Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson Disease.” JAMA Neurology, vol. 82, no. 1, 2025, pp. 1–12. doi:10.1001/jamaneurol.2024.5678.
6. Deuschl G et al, Improvement in Quality of Life and motor function: Real-world, Prospective Study of Directional DBS Systems, AAN meeting 2023.
View Boston Scientific Deep Brain System Indications, Safety, and Warnings